Allscripts (MDRX) and Express Scripts (ESRX) have announced the deployment of Allscripts eAuth, a new electronic prior authorization (ePA) solution that transacts an electronic prior authorization for Express Scripts patients, replacing the costly, time-consuming, and labor-intensive process of manual prior authorization.
Leveraging Allscripts for operational efficiencies
Allscripts eAuth is integrated within the physician electronic prescription workflow. While writing a prescription, users will be prompted to conduct prior authorization electronically with Express Scripts, saving time and leading to faster prior authorization decisions.
The new feature will allow real-time provider-based prior authorization for prescriptions when required. This digital approach can decrease the need for follow-up phone calls, faxes, and other manual processes related to retrospective pre-authorization which today occurs after the prescription is written and which can take as long as days or weeks. Allscripts eAuth will be integrated into all Allscripts EHR platforms in the coming months.
“Electronic prior authorization is a major enhancement that returns coverage decisions instantaneously and dramatically improves efficiency for physicians, while continuing to safeguard patients from treatment that may be harmful, ineffective or more costly than need be,” said Dr. Glen Stettin, Senior Vice President of Clinical Research & New Solutions at Express Scripts.
Express Scripts, based in St. Louis, Mo., provides integrated PBM services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Building on Allscripts leadership in e-prescribing and prior authorization
According to a study by industry analysts, the electronic prescribing systems market is estimated to grow at a compound annual growth rate of 26 percent from 2012 to 2017. Allscripts ePrescribe is one of the most widely used electronic prescribing applications in the U.S, with Allscripts providers averaging 150 million electronic prescriptions per year. ePrescribe can help improve the efficiency of the prescription process and provides tools to assist with medication compliance through patient adherence and patient assistance program capabilities. Importantly, ePrescribe provides tools to help providers improve patient safety through automatic drug interaction checking and dosage, adverse reaction, and duplicate therapy checks.
“Allscripts continues to lead the industry with solutions that deliver significant value to our providers and our partners,” said Faisal Mushtaq, Senior Vice President and General Manager of Allscripts Payer and Life Sciences business unit. “We are excited to be working with Express Scripts to develop this prior authorization solution that can help save money, time and reduce errors, which in turn improves patient outcomes.”
Allscripts has helped set the standard for prior authorization, being one of the first to market with a solution in 2011.
Allscripts eAuth is part of a suite of Allscripts solutions that provide functionality and content delivered seamlessly into current workflow, so as to help users maximize cost savings and improve efficiencies.
The focus of Allscripts Payer and Life Sciences business is innovations and solutions that add additional value for clients by providing valuable content at the point of care. These products supplement the EHR and improve the patient experience, potentially saving time and reducing costs.
Allscripts (MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health(TM). Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.